Grace C John-Stewart

University Of Washington

$42,921,726

Attributed

$55,204,090

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $12.6M · FY2005–25

$20M$15M$10M$5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$67,667,841 · 26

By mechanism

R01$34,509,670 · 10

P01$9,465,488 · 3

U19$7,756,597 · 2

P30$5,406,531 · 3

UH3$3,122,317 · 1

R33$2,621,605 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Robert E Braun$36,663,443
Lisa M Frenkel$29,105,317
Sylvia Lacourse$6,414,195
Jason Simmons$950,508
Kenneth Sherr$9,300,980

Others in their field

Top investigators on “Cohort”

David R. Weir · University Of Michigan At Ann Arbor$406,814,098
George R Seage · Abt Associates, Inc.$297,656,361
Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
James Dennis Neaton · Northwestern University$203,539,316

Research focus

CohortKenyaChildProgramsInfantAdultAfricaBaseFollow-UpWomanInfectionChildhoodHiv InfectionsClinicViralPreventionLifeImmuneImmune ResponseCofactorEvaluationAntiretroviral TherapyEnrollmentAnti-Retroviral Agents

Grant awards (118)

Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV$4,882,653

U19 · FY2025 · HD · contact PI

Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection$1,508,882

P01 · FY2025 · HD · contact PI

Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV in Southern and Eastern Africa (RISE)$1,121,250

U19 · FY2025 · HD · contact PI

Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV$939,977

U19 · FY2025 · HD · contact PI

B: Developmental$928,932

P30 · FY2025 · AI · contact PI

Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV$812,717

U19 · FY2025 · HD · contact PI

Pediatric HIV reservoir determinants and consequences$755,342

R01 · FY2025 · HD · contact PI

Impact of HIV and toxic metals exposure on neurodevelopment at school age$734,151

R01 · FY2025 · HD · contact PI

Scale-up of an evidence-based Adolescent Transition Package to support transitional care among youth living with HIV$612,396

R01 · FY2025 · MH · contact PI

Administrative Core$301,777

P01 · FY2025 · HD · contact PI

HEU outcomes: population-evaluation and screening strategies (HOPE)$989,559

R33 · FY2024 · HD · contact PI

B: Developmental$768,158

P30 · FY2024 · AI · contact PI

Pediatric HIV reservoir determinants and consequences$755,327

R01 · FY2024 · HD · contact PI

Scale-up of an evidence-based Adolescent Transition Package to support transitional care among youth living with HIV$625,598

R01 · FY2024 · MH · contact PI

B: Developmental$224,721

P30 · FY2024 · AI · contact PI

B: Developmental$214,866

P30 · FY2024 · AI · contact PI

B: Developmental$178,593

P30 · FY2024 · AI · contact PI

B: Developmental$1,102,937

P30 · FY2023 · AI · contact PI

The effect of HIV exposure and infection on immunity to TB in children$774,996

R01 · FY2023 · AI · contact PI

Pediatric HIV reservoir determinants and consequences$754,936

R01 · FY2023 · HD · contact PI

HEU outcomes: population-evaluation and screening strategies (HOPE)$670,100

R33 · FY2023 · HD · contact PI

HEU outcomes: population-evaluation and screening strategies (HOPE)$298,428

R33 · FY2023 · HD · contact PI

Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection$4,319,522

P01 · FY2022 · HD · contact PI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes$959,172

UH3 · FY2022 · HD

The effect of HIV exposure and infection on immunity to TB in children$774,910

R01 · FY2022 · AI · contact PI

Pediatric HIV reservoir determinants and consequences$770,974

R01 · FY2022 · HD · contact PI

HEU outcomes: population-evaluation and screening strategies (HOPE)$663,518

R33 · FY2022 · HD · contact PI

Administrative Core$652,056

P01 · FY2022 · HD · contact PI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes$299,700

UH3 · FY2022 · HD

The effect of HIV exposure and infection on immunity to TB in children$70,609

R01 · FY2022 · AI · contact PI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes$928,664

UH3 · FY2021 · HD

The effect of HIV exposure and infection on immunity to TB in children$783,833

R01 · FY2021 · AI · contact PI

Infant immune mechanisms of HIV reservoir size and decay$669,239

R01 · FY2021 · HD · contact PI

PrEP Adherence Among AGYW: A Multidimensional Evaluation$573,023

R01 · FY2021 · HD · contact PI

HEU outcomes: population-evaluation and screening strategies (HOPE)$382,638

R61 · FY2021 · HD · contact PI

The effect of HIV exposure and infection on immunity to TB in children$77,872

R01 · FY2021 · AI · contact PI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes$934,781

UH3 · FY2020 · HD

The effect of HIV exposure and infection on immunity to TB in children$793,352

R01 · FY2020 · AI · contact PI

Infant immune mechanisms of HIV reservoir size and decay$675,257

R01 · FY2020 · HD · contact PI

Delivering PrEP in Pregnancy$653,112

R01 · FY2020 · AI · contact PI

PrEP Adherence Among AGYW: A Multidimensional Evaluation$596,294

R01 · FY2020 · HD · contact PI

Transitioning from Pediatric to Adult HIV Care in Kenya$565,187

R01 · FY2020 · HD · contact PI

HEU outcomes: population-evaluation and screening strategies (HOPE)$397,477

R61 · FY2020 · HD · contact PI

Delivering PrEP in Pregnancy$979,818

R01 · FY2019 · AI · contact PI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes$848,971

UG3 · FY2019 · HD

The effect of HIV exposure and infection on immunity to TB in children$828,368

R01 · FY2019 · AI · contact PI

Infant immune mechanisms of HIV reservoir size and decay$737,227

R01 · FY2019 · HD · contact PI

PrEP Adherence Among AGYW: A Multidimensional Evaluation$644,445

R01 · FY2019 · HD · contact PI

Transitioning from Pediatric to Adult HIV Care in Kenya$423,025

R01 · FY2019 · HD · contact PI

Transitioning from Pediatric to Adult HIV Care in Kenya Administrative Supplement$214,111

R01 · FY2019 · HD · contact PI

PrEP optimized for mothers (PrOM): efficient PrEP integration in MCH clinics$211,815

R01 · FY2019 · HD · contact PI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes$153,635

UG3 · FY2019 · HD

Delivering PrEP in Pregnancy$38,409

R01 · FY2019 · AI · contact PI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes$858,358

UG3 · FY2018 · HD

Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART$751,855

R01 · FY2018 · HD · contact PI

Infant immune mechanisms of HIV reservoir size and decay$724,236

R01 · FY2018 · HD · contact PI

PrEP Adherence Among AGYW: A Multidimensional Evaluation$656,231

R01 · FY2018 · HD · contact PI

Delivering PrEP in Pregnancy$630,386

R01 · FY2018 · AI · contact PI

Transitioning from Pediatric to Adult HIV Care in Kenya$349,875

R01 · FY2018 · HD · contact PI

Transitioning from Pediatric to Adult HIV Care in Kenya$73,150

R01 · FY2018 · HD · contact PI

Infant immune mechanisms of HIV reservoir size and decay$778,821

R01 · FY2017 · HD · contact PI

Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART$713,099

R01 · FY2017 · HD · contact PI

PrEP Adherence Among AGYW: A Multidimensional Evaluation$634,097

R01 · FY2017 · HD · contact PI

Delivering PrEP in Pregnancy$634,032

R01 · FY2017 · AI · contact PI

International$359,971

P30 · FY2017 · AI · contact PI

Transitioning from Pediatric to Adult HIV Care in Kenya$348,750

R01 · FY2017 · HD · contact PI

Delivering PrEP in Pregnancy$666,457

R01 · FY2016 · AI · contact PI

Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART$664,262

R01 · FY2016 · HD · contact PI

Transitioning from Pediatric to Adult HIV Care in Kenya$347,625

R01 · FY2016 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$120,011

K24 · FY2016 · HD · contact PI

Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART$698,914

R01 · FY2015 · HD · contact PI

Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infections$529,642

R01 · FY2015 · HD · contact PI

Hiv-1 Counseling and Testing for Children at Home (CATCH)$131,533

R21 · FY2015 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$120,802

K24 · FY2015 · HD · contact PI

Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART$685,067

R01 · FY2014 · HD · contact PI

Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infections$530,571

R01 · FY2014 · HD · contact PI

Hiv-1 Counseling and Testing for Children at Home (CATCH)$241,934

R21 · FY2014 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$121,216

K24 · FY2014 · HD · contact PI

Incidence, timing and cofactors that contribute to the high risk of HIV-1 Infect$539,211

P01 · FY2013 · HD · contact PI

Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infection$520,396

R01 · FY2013 · HD · contact PI

International$253,610

P30 · FY2013 · AI · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$121,532

K24 · FY2013 · HD · contact PI

Incidence, timing and cofactors that contribute to the high risk of HIV-1 Infect$570,254

P01 · FY2012 · HD · contact PI

Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infection$550,751

R01 · FY2012 · HD · contact PI

International$347,720

P30 · FY2012 · AI · contact PI

Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infection$186,278

R01 · FY2012 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$121,056

K24 · FY2012 · HD · contact PI

Incidence, timing and cofactors that contribute to the high risk of HIV-1 Infect$572,064

P01 · FY2011 · HD · contact PI

Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infection$563,531

R01 · FY2011 · HD · contact PI

International$377,016

P30 · FY2011 · AI · contact PI

Optimizing pediatric HIV-1 therapy$689,715

R01 · FY2010 · HD · contact PI

Incidence, timing and cofactors that contribute to the high risk of HIV-1 Infect$523,101

P01 · FY2010 · HD · contact PI

International$206,685

P30 · FY2010 · AI · contact PI

Latent TB Detection and Implications in HIV-1 Infected Women and Their Children$116,357

R21 · FY2010 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$114,059

K24 · FY2010 · HD · contact PI

Optimizing pediatric HIV-1 therapy$687,985

R01 · FY2009 · HD · contact PI

Incidence, timing and cofactors that contribute to the high risk of HIV-1 Infect$478,621

P01 · FY2009 · HD · contact PI

International$222,382

P30 · FY2009 · AI · contact PI

Latent TB Detection and Implications in HIV-1 Infected Women and Their Children$189,475

R21 · FY2009 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$112,310

K24 · FY2009 · HD · contact PI

Optimizing pediatric HIV-1 therapy$686,263

R01 · FY2008 · HD · contact PI

International$220,940

P30 · FY2008 · AI · contact PI

Latent TB Detection and Implications in HIV-1 Infected Women and Their Children$183,729

R21 · FY2008 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$110,610

K24 · FY2008 · HD · contact PI

Optimizing pediatric HIV-1 therapy$628,952

R01 · FY2007 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$108,162

K24 · FY2007 · HD · contact PI

Optimizing pediatric HIV-1 therapy$54,785

R01 · FY2007 · HD · contact PI

Optimizing pediatric HIV-1 therapy$617,387

R01 · FY2006 · HD · contact PI

Pediatric HIV-1 in Africa: Pathogenesis and Management$106,028

K24 · FY2006 · HD · contact PI

CCR5 and CXCR4 Binding Chemokines and Oral HIV Infection$301,550

R01 · FY2005 · DE

CCR5 and CXCR4 Binding Chemokines and Oral HIV Infection$285,067

R01 · FY2004 · DE

CTLS AND PREVENTION OF BREASTMILK HIV1 TRANSMISSION$556,371

R01 · FY2003 · HD

CCR5 and CXCR4 Binding Chemokines and Oral HIV Infection$284,927

R01 · FY2003 · DE

HIV-1 Specific Cytotoxic T Lymphocytes in Breastmilk$62,740

R03 · FY2003 · HD

CTLS AND PREVENTION OF BREASTMILK HIV1 TRANSMISSION$535,516

R01 · FY2002 · HD

CCR5 and CXCR4 Binding Chemokines and Oral HIV Infection$294,058

R01 · FY2002 · DE

HIV-1 Specific Cytotoxic T Lymphocytes in Breastmilk$63,000

R03 · FY2002 · HD

CTLS AND PREVENTION OF BREASTMILK HIV1 TRANSMISSION$555,442

R01 · FY2001 · HD